Literature DB >> 1491391

The utility of the arthritis impact measurement scales for patients with psoriatic arthritis.

C M Duffy1, K N Watanabe Duffy, D D Gladman, B B Brubacher, D Buskila, P Langevitz, V T Farewell.   

Abstract

The Arthritis Impact Measurement Scales (AIMS) consists of 9 scales that measure physical function, pain and psychosocial function. It has been validated for use in various forms of arthritis, but not in psoriatic arthritis (PsA). The AIMS was administered to 145 patients attending our PsA clinic. We carried out simultaneous assessment of clinical measures of function, measures of disease activity, and measures of disease severity. Most scales of physical function were moderately to highly correlated with clinical measures of function (r = 0.33-0.57; p = 0.0001), measures of disease activity (r = 0.24-0.53, p = 0.003-0.0001), and measures of disease severity (r = 0.23-0.6; p = 0.02-0.0001). The pain scale was highly correlated with clinical measures of function and measures of disease activity (r = 0.38-0.58; p = 0.0001) but not with measures of disease severity. Of the psychosocial scales, the depression scale was moderately correlated with clinical measures of function (r = 0.27-0.3; p = 0.001-0.0001). Our data suggest that the physical function and pain scales are good indicators of overall function and disease activity and are valid for use in PsA.

Entities:  

Mesh:

Year:  1992        PMID: 1491391

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  6 in total

Review 1.  Science of assessment.

Authors:  N Bellamy
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

Review 2.  Impairment measures in rheumatic disorders for rehabilitation medicine and allied health care: a systematic review.

Authors:  Raymond A H M Swinkels; Lex M Bouter; Rob A B Oostendorp; Cornelia H M van den Ende
Journal:  Rheumatol Int       Date:  2005-06-24       Impact factor: 2.631

Review 3.  Clinical, radiological, and functional assessment in psoriatic arthritis: is it different from other inflammatory joint diseases?

Authors:  D D Gladman
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

Review 4.  Psoriatic arthritis and psoriasis: role of patient advocacy organisations in the twenty first century.

Authors:  G M Zimmerman; L M Savage; D C Chandler; M Maccarone Buonfigli
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

5.  Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis.

Authors:  S P McKenna; L C Doward; D Whalley; A Tennant; P Emery; D J Veale
Journal:  Ann Rheum Dis       Date:  2004-02       Impact factor: 19.103

Review 6.  Patient involvement in outcome measures for psoriatic arthritis.

Authors:  William Tillett; Ade Adebajo; Mel Brooke; Willemina Campbell; Laura C Coates; Oliver FitzGerald; Laure Gossec; Philip Helliwell; Sarah Hewlett; Jana James; Patricia Minnock; Aisling Reast; Dennis O'Sullivan; Maarten de Wit; Neil McHugh
Journal:  Curr Rheumatol Rep       Date:  2014-05       Impact factor: 4.592

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.